本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Fulcrum Therapeutics

7.84
-0.0600-0.76%
盤後7.840.00000.00%16:24 EDT
成交量:35.72萬
成交額:277.72萬
市值:4.23億
市盈率:-954.82
高:8.04
開:7.92
低:7.62
收:7.90
資料載入中...
2023/08/03

重要事件披露

Form 8-K - Current report
2023/08/03

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/11

重要事件披露

Form 8-K - Current report
2023/06/26

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2023/06/26

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2023/06/24

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2023/06/10

重要事件披露

Form 8-K - Current report
2023/05/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/15

重要事件披露

Form 8-K - Current report
2023/04/05

重要事件披露

8-K - Current report
2023/03/09

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/09

重要事件披露

8-K - Current report
2023/03/09

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/06

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/23

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals